share_log

港股异动 | 小鹏汽车-W(09868)一度涨超3% 开年首周夺得新势力销冠 机构指其有望开启强新车周期

Hong Kong stocks movement | Xiaopeng Autos-W (09868) once rose over 3%, capturing the sales champion of new forces in the first week of the year. Institutions pointed out that it is expected to start a strong new car cycle.

Zhitong Finance ·  Jan 6 22:37

Xpeng Autos-W (09868) rose in the afternoon and turned positive, with an intra-day increase of over 3%. As of the time of writing, it is up 2.38%, reported at 47.3 Hong Kong dollars, with a trading volume of 0.719 billion Hong Kong dollars.

According to Zhito Finance APP, Xpeng Motors-W (09868) surged in the afternoon, at one point rising over 3%. As of the time of writing, it is up 2.38%, priced at 47.3 HKD, with a transaction volume of 0.719 billion HKD.

In terms of news, on January 7, the sales ranking of new force brands in the Chinese market released by Ideal Motors shows that in the first week of 2025, Xpeng ranks first in sales among new force brands in the Chinese market, with weekly sales of 0.007 million units, ending Ideal's consecutive sales championship for 36 weeks. It is reported that Xpeng delivered 0.037 million new cars in December 2024, an increase of 82% year-on-year. In 2024, Xpeng Motors accumulated deliveries of 0.19 million units, an increase of 34.2% year-on-year.

Guolian Securities stated that after completing the management structure adjustment, Xpeng has the capability to create popular models and achieve stable sales. In 2025, Xpeng Motors will update older models like the G6/G9, while also filling the current product matrix gaps based on the Fuyiao architecture, which is expected to initiate a strong new car cycle in the future. CITIC SEC previously pointed out that after two years of organizational restructuring, Xpeng Motors has completed iterations in product concepts, cost structure, marketing, and promotion, laying a solid foundation for the large product cycle in 2025-2026.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment